A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV)

Meir Bialer, Svein I Johannessen, Matthias J Koepp, René H Levy, Emilio Perucca, Torbjörn Tomson, H Steve White

Research output: Contribution to journalArticle

Abstract

The Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV) took place in Madrid, Spain from May 13th to 16th 2018. Again, presentations on new medical devices and neuromodulation and discussions on device-related regulatory aspects were included in the programme. The virtual special issue on "neuromodulation" summarises the presentations focusing firstly, on the pre-clinical developments and the difficulties of clinical trial designs for neuromodulatory therapies, including vagus nerve stimulation (VNS) and Brain-Responsive Neurostimulation (RNS), and the use of transcutaneous vagus nerve stimulation (tVNS) as a potential screening tool for determining the efficacy of neuromodulatory treatments in individual patients; secondly, on wearable devices for seizure monitoring through indices of peripheral sympathetic nervous activity, the use of such devices in combination with biofeedback for the treatment of epilepsy, and its potential for improving epilepsy specialist services, particularly in remote areas.

Original languageEnglish
JournalEpilepsy Research
DOIs
Publication statusE-pub ahead of print - Mar 11 2019

Fingerprint

Anticonvulsants
Equipment and Supplies
Vagus Nerve Stimulation
Epilepsy
Transcutaneous Electric Nerve Stimulation
Spain
Seizures
Clinical Trials
Brain
Therapeutics

Cite this

A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV). / Bialer, Meir; Johannessen, Svein I; Koepp, Matthias J; Levy, René H; Perucca, Emilio; Tomson, Torbjörn; White, H Steve.

In: Epilepsy Research, 11.03.2019.

Research output: Contribution to journalArticle

Bialer, Meir ; Johannessen, Svein I ; Koepp, Matthias J ; Levy, René H ; Perucca, Emilio ; Tomson, Torbjörn ; White, H Steve. / A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV). In: Epilepsy Research. 2019.
@article{a9c0bfdbd4da4223b612d0be99cd1969,
title = "A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV)",
abstract = "The Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV) took place in Madrid, Spain from May 13th to 16th 2018. Again, presentations on new medical devices and neuromodulation and discussions on device-related regulatory aspects were included in the programme. The virtual special issue on {"}neuromodulation{"} summarises the presentations focusing firstly, on the pre-clinical developments and the difficulties of clinical trial designs for neuromodulatory therapies, including vagus nerve stimulation (VNS) and Brain-Responsive Neurostimulation (RNS), and the use of transcutaneous vagus nerve stimulation (tVNS) as a potential screening tool for determining the efficacy of neuromodulatory treatments in individual patients; secondly, on wearable devices for seizure monitoring through indices of peripheral sympathetic nervous activity, the use of such devices in combination with biofeedback for the treatment of epilepsy, and its potential for improving epilepsy specialist services, particularly in remote areas.",
author = "Meir Bialer and Johannessen, {Svein I} and Koepp, {Matthias J} and Levy, {Ren{\'e} H} and Emilio Perucca and Torbj{\"o}rn Tomson and White, {H Steve}",
note = "Copyright {\circledC} 2019 Elsevier B.V. All rights reserved.",
year = "2019",
month = "3",
day = "11",
doi = "10.1016/j.eplepsyres.2019.03.002",
language = "English",
journal = "Epilepsy Research",
issn = "0920-1211",
publisher = "Elsevier",

}

TY - JOUR

T1 - A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV)

AU - Bialer, Meir

AU - Johannessen, Svein I

AU - Koepp, Matthias J

AU - Levy, René H

AU - Perucca, Emilio

AU - Tomson, Torbjörn

AU - White, H Steve

N1 - Copyright © 2019 Elsevier B.V. All rights reserved.

PY - 2019/3/11

Y1 - 2019/3/11

N2 - The Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV) took place in Madrid, Spain from May 13th to 16th 2018. Again, presentations on new medical devices and neuromodulation and discussions on device-related regulatory aspects were included in the programme. The virtual special issue on "neuromodulation" summarises the presentations focusing firstly, on the pre-clinical developments and the difficulties of clinical trial designs for neuromodulatory therapies, including vagus nerve stimulation (VNS) and Brain-Responsive Neurostimulation (RNS), and the use of transcutaneous vagus nerve stimulation (tVNS) as a potential screening tool for determining the efficacy of neuromodulatory treatments in individual patients; secondly, on wearable devices for seizure monitoring through indices of peripheral sympathetic nervous activity, the use of such devices in combination with biofeedback for the treatment of epilepsy, and its potential for improving epilepsy specialist services, particularly in remote areas.

AB - The Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV) took place in Madrid, Spain from May 13th to 16th 2018. Again, presentations on new medical devices and neuromodulation and discussions on device-related regulatory aspects were included in the programme. The virtual special issue on "neuromodulation" summarises the presentations focusing firstly, on the pre-clinical developments and the difficulties of clinical trial designs for neuromodulatory therapies, including vagus nerve stimulation (VNS) and Brain-Responsive Neurostimulation (RNS), and the use of transcutaneous vagus nerve stimulation (tVNS) as a potential screening tool for determining the efficacy of neuromodulatory treatments in individual patients; secondly, on wearable devices for seizure monitoring through indices of peripheral sympathetic nervous activity, the use of such devices in combination with biofeedback for the treatment of epilepsy, and its potential for improving epilepsy specialist services, particularly in remote areas.

U2 - 10.1016/j.eplepsyres.2019.03.002

DO - 10.1016/j.eplepsyres.2019.03.002

M3 - Article

C2 - 30910314

JO - Epilepsy Research

JF - Epilepsy Research

SN - 0920-1211

ER -